Literature DB >> 19785043

Correlation between Etest, disk diffusion, and microdilution methods for antifungal susceptibility testing of Candida species from infection and colonization.

Melyssa Negri1, Mariana Henriques, Terezinha I E Svidzinski, Claudete Rodrigues Paula, Rosário Oliveira.   

Abstract

The correlation between the microdilution (MD), Etest (ET), and disk diffusion (DD) methods was determined for amphotericin B, itraconazole and fluconazole. The minimal inhibitory concentration (MIC) of those antifungal agents was established for a total of 70 Candida spp. isolates from colonization and infection. The species distribution was: Candida albicans (n=27), C. tropicalis (n=17), C. glabrata (n=16), C. parapsilosis (n=8), and C. lusitaniae (n=2). Non-Candida albicans Candida species showed higher MICs for the three antifungal agents when compared with C. albicans isolates. The overall concordance (based on the MIC value obtained within two dilutions) between the ET and the MD method was 83% for amphotericin B, 63% for itraconazole, and 64% for fluconazole. Considering the breakpoint, the agreement between the DD and MD methods was 71% for itraconazole and 67% for fluconazole. The DD zone diameters are highly reproducible and correlate well with the MD method, making agar-based methods a viable alternative to MD for susceptibility testing. However, data on agar-based tests for itraconazole and amphotericin B are yet scarce. Thus, further research must still be carried out to ensure the standardization to other antifungal agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19785043      PMCID: PMC6649251          DOI: 10.1002/jcla.20337

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  26 in total

1.  Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.

Authors:  Charles R Sims; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; Luis Ostrosky-Zeichner
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.

Authors:  Ralf Fleck; Annebärbel Dietz; Herbert Hof
Journal:  J Antimicrob Chemother       Date:  2007-02-09       Impact factor: 5.790

4.  A quantitative study of the survival of two species of Candida on porous and non-porous environmental surfaces and hands.

Authors:  O Traoré; V S Springthorpe; S A Sattar
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

5.  High frequency of Candida parapsilosis on the hands of healthy hosts.

Authors:  L A Bonassoli; M Bertoli; T I E Svidzinski
Journal:  J Hosp Infect       Date:  2005-02       Impact factor: 3.926

6.  Evaluation of Etest and macrodilution broth method for antifungal susceptibility testing of Candida sp strains isolated from oral cavities of AIDS patients.

Authors:  Maria do Rosário R Silva; Márcio R Costa; André T B Miranda; Orionalda de F L Fernandes; Carolina R Costa; Claudete R de Paula
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2002 May-Jun       Impact factor: 1.846

7.  Evaluation of the adherence of Candida species to urinary catheters.

Authors:  N K Tamura; A Gasparetto; T I E Svidzinski
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

8.  Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole.

Authors:  M A Pfaller; L Boyken; S A Messer; R J Hollis; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Shifting patterns in the epidemiology of nosocomial Candida infections.

Authors:  David R Snydman
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

10.  Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit.

Authors:  Jennifer K Chow; Yoav Golan; Robin Ruthazer; Adolf W Karchmer; Yehuda Carmeli; Deborah Lichtenberg; Varun Chawla; Janet Young; Susan Hadley
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

View more
  10 in total

1.  In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice?

Authors:  Susanne Perkhofer; Cornelia Mrazek; Lukas Hartl; Cornelia Lass-Flörl
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

Review 2.  Insights into Candida tropicalis nosocomial infections and virulence factors.

Authors:  M Negri; S Silva; M Henriques; R Oliveira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-30       Impact factor: 3.267

3.  Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei.

Authors:  Yasemin Oz; Ilknur Dag; Nuri Kiraz
Journal:  Mycopathologia       Date:  2011-08-13       Impact factor: 2.574

4.  Raman Spectroscopy of Oral Candida Species: Molecular-Scale Analyses, Chemometrics, and Barcode Identification.

Authors:  Giuseppe Pezzotti; Miyuki Kobara; Tamaki Nakaya; Hayata Imamura; Nao Miyamoto; Tetsuya Adachi; Toshiro Yamamoto; Narisato Kanamura; Eriko Ohgitani; Elia Marin; Wenliang Zhu; Ichiro Nishimura; Osam Mazda; Tetsuo Nakata; Koichi Makimura
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

5.  Uncommon Non-Candida Yeasts in Healthy Turkeys-Antimicrobial Susceptibility and Biochemical Characteristic of Trichosporon Isolates.

Authors:  Kamila Bobrek; Ireneusz Sokół; Andrzej Gaweł
Journal:  Pathogens       Date:  2021-04-30

6.  Antifungal profile of vulvovaginal candidiasis in sexually active females from a tertiary care hospital of Western Rajasthan.

Authors:  Sarika P Kombade; Kumar S Abhishek; Payal Mittal; Charu Sharma; Pratibha Singh; Vijaya L Nag
Journal:  J Family Med Prim Care       Date:  2021-01-30

7.  Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis.

Authors:  You Bum Song; Moo Kyu Suh; Gyoung Yim Ha; Heesoo Kim
Journal:  Ann Dermatol       Date:  2015-12-07       Impact factor: 1.444

8.  Antifungal Drug Susceptibility of Candida Species Isolated from HIV-Positive Patients Recruited at a Public Hospital in São Luís, Maranhão, Brazil.

Authors:  Ana L G Terças; Sirlei G Marques; Eduardo B Moffa; Márcia B Alves; Conceição M P S de Azevedo; Walter L Siqueira; Cristina A Monteiro
Journal:  Front Microbiol       Date:  2017-03-02       Impact factor: 5.640

9.  E-test Determination of Antifungal Susceptibility of Candida Species Isolated from Turkeys.

Authors:  Ireneusz Sokół; Stanisław Tokarzewski; Kamila Bobrek; Andrzej Gaweł
Journal:  J Vet Res       Date:  2020-11-10       Impact factor: 1.744

10.  Susceptibility tests of oropharyngeal Candida albicans from egyptian patients to fluconazole determined by three methods.

Authors:  Noha El-Mashad; Mona F Foad; Niveen Saudy; Dalia A Salem
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.